Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform   YONGIN, South Korea, Dec. 22, 2025 /PRNewswire/ -- GC Biopharma (006280 ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

FUJIFILM Corporation today announced the completion of one of Japan’s largest bio CDMO*1 facilities (the new plant) at the ...

MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

Researchers have uncovered the immune signaling pathway responsible for rare mRNA vaccine–associated myocarditis and showed ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.